Prices delayed by at least 15 minutes | Print


REIG JOFRE (RJF)

LABORATORIO REIG JOFRE, S.A.
Change: 0.04 (1.60%)

Open 

€2.5


Previous close 

€2.5


Trade high 

€2.58


Volume 

4,064


Year high 

€2.88


Year low 

€2.15


Dividend yield 

1.6%


Market capitalisation 

€200.15 mn


P/E ratio 

20.83


ISIN 

ES0165359029


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 03/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
REIG JOFRE+ 1.60
More...

Company profile

Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.